|MiMedx Group, Inc.|
1775 West Oak Commons Court NE
United States - Map
MiMedx Group, Inc., together with its subsidiaries, operates as an integrated developer, manufacturer, and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane. The companys biomaterial platform technologies include HydroFix and CollaFix device technologies; and AmnioFix and EpiFix tissue technologies. Its tissue technologies, processed from the human amniotic membrane, utilize its proprietary Purion process to produce minimally manipulated implants. The company supplies amniotic tissues to distributors and original equipment manufacturers for application in the surgical, ophthalmic, orthopedics, spine, wound care, and dental sectors of healthcare. MiMedx Group sells its products through a combination of a direct sales force, independent stocking distributors, and representatives in the United States, as well as through independent distributors internationally. The company is headquartered in Marietta, Georgia.
|Mr. Parker H. Petit ,
Chairman and Chief Exec. Officer
|Mr. William Charles Taylor ,
Pres, Chief Operating Officer and Director
|Mr. Michael J. Senken ,
Chief Financial Officer, Principal Accounting Officer and VP
|Dr. Thomas J. Koob Ph.D.,
Exec. VP and Chief Scientific Officer
|Mr. Thornton Kuntz Jr.,
VP of HR & Admin.
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|